News
IDIBELL researchers define a new mechanism of aging in a bone marrow stem cell in women
To equilibrate the gene expression between XX females and XY males, one of female X chromosomes is inactivated. Researchers from IDIBELL Regenerative Program has discovered that this inactivation is affected in bone marrow aged stem cells.
Years of disease have a decisive impact on the response to the treatment of eating disorders (ED)
A study by IDIBELL and Bellvitge Hospital establishes, for the first time, a temporary criterion for the risk of chronicity of symptoms for the different subtypes of ED.
Researchers define the clinical characteristics of the cerebral complications caused by oncological immunotherapies that determine the evolution
The study describes two syndromes, which combine clinical manifestations and differential cerebrospinal fluid profiles, which determine a different prognosis in patients.
Possible new biomarker for Parkinson’s disease
The biomarker candidate is a fragment of a neuronal receptor that can be detected in the cerebrospinal fluid.
A study predicts that in 2030 there will be more cases and more deaths from endometrial cancer in Catalonia among women over 65 years-old
The data obtained show a decrease in the incidence and a slight increase in mortality from endometrial cancer. The study was conducted by the Infections and Cancer research group from IDIBELL, ICO, and the Oncology Master Plan.
Dr. Xavier Matias-Guiu, the new president of the International Society of Gynecological Pathologists
Dr. Xavier Matias-Guiu, head of the gynecological cancer research group at IDIBELL, is the new president of the International Society of Gynecological Pathologists (ISGYP) since this weekend.
Early detection of deteriorating by nursing staff improves COVID-19 patient recovery
A study finds that systematized nursing surveillance through the VIDA system, developed by the Catalan Institute of Health and IDIBELL, can detect and prevent complications, transfers to the ICU, and intra-hospital mortality.
Anna Sureda, new president of the European Society for Bone Marrow Transplantation
This appointment represents a recognition of her professional life dedicated to hematopoietic stem cell transplantation and cell therapies.